CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: SLC12A6 (ImmuneEditome ID:9990)

1. Gene summary of enriched editing regions for SLC12A6

check button Gene summary
Gene informationGene symbol

SLC12A6

Gene ID

9990

GeneSynonymsACCPN|CMT2II|KCC3|KCC3A|KCC3B
GeneCytomap

15q14

GeneTypeprotein-coding
GeneDescriptionsolute carrier family 12 member 6|K-Cl cotransporter 3|electroneutral potassium-chloride cotransporter 3|potassium chloride cotransporter 3|potassium chloride cotransporter KCC3a-S3|potassium-chloride transporter-3a|potassium-chloride transporter-3b|solute carrier family 12 (potassium/chloride transporter), member 6|solute carrier family 12 (potassium/chloride transporters), member 6
GeneModificationdate20230518
UniprotIDQ9UHW9;A0A024R9I5;B3KXX3;H0YMQ9;A0A6Q8PH21;H0YKE6;H0YKQ8;H0YKJ2;H0YKL8;A0A024R9K8
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr15:34231060-34232550:-ENST00000290209.8ENSG00000140199.10SLC12A6UTR3AluSz,AluSp,AluYchr15:34231060-34232550:-.alignment
chr15:34249281-34250056:-ENST00000290209.8ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000354181.6ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000397702.5ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000397707.5ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000458406.5ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000558589.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000558667.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000559523.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000559664.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000560164.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000560611.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34249281-34250056:-ENST00000561080.4ENSG00000140199.10SLC12A6intronicAluJb,AluJo,GA-richchr15:34249281-34250056:-.alignment
chr15:34270150-34270647:-ENST00000290209.8ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000354181.6ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000397702.5ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000397707.5ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000458406.5ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000558589.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000558667.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000559236.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000559484.1ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000559523.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000559664.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000560164.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000560332.1ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000560611.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000561080.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34270150-34270647:-ENST00000561120.4ENSG00000140199.10SLC12A6intronicAluSx1,L1MC5,THE1D,AluJr4chr15:34270150-34270647:-.alignment
chr15:34286153-34286723:-ENST00000290209.8ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000354181.6ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000397702.5ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000397707.5ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000458406.5ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000558589.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000558667.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000559236.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000559484.1ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000559523.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000559664.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000560164.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000560332.1ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000560611.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000561080.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment
chr15:34286153-34286723:-ENST00000561120.4ENSG00000140199.10SLC12A6intronicL1MB2,AluSx1,AluSzchr15:34286153-34286723:-.alignment


Top

2. Tumor-specific enriched editing regions for SLC12A6


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr15:34231060-34232550:-BRCAEER2.6548e-11image
ENSG00000140199.10,SLC12A6BRCAEAG3.0826e-11image
chr15:34231060-34232550:-HNSCEER5.5613e-05image
ENSG00000140199.10,SLC12A6HNSCEAG5.5613e-05image
chr15:34231060-34232550:-KIRCEER7.8927e-05image
ENSG00000140199.10,SLC12A6KIRCEAG6.8368e-05image
chr15:34231060-34232550:-LUADEER2.9725e-04image
ENSG00000140199.10,SLC12A6LUADEAG2.6193e-04image
chr15:34231060-34232550:-LUSCEER4.7457e-03image
ENSG00000140199.10,SLC12A6LUSCEAG5.3703e-03image
chr15:34231060-34232550:-THCAEER2.8989e-08image
ENSG00000140199.10,SLC12A6THCAEAG2.8989e-08image
chr15:34231060-34232550:-UCECEER5.7019e-06image
ENSG00000140199.10,SLC12A6UCECEAG4.7430e-06image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr15:34231060-34232550:-KIRCPathEER3.3929e-051.4028e-060.2157image
ENSG00000140199.10,SLC12A6KIRCPathEAG9.5367e-054.0633e-060.2062image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for SLC12A6


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr15:34231060-34232550:-CESCEERENSG00000140199,SLC12A6-0.42011.4157e-092.7397e-12-0.4052imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAMacrophages_M1GSVA_HALLMARK_P53_PATHWAY
chr15:34231060-34232550:-GBMEERENSG00000140199,SLC12A6-0.56569.8451e-101.4345e-11-0.5028imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NANeutrophilsGSVA_HALLMARK_MITOTIC_SPINDLE
chr15:34231060-34232550:-GBMEERENSG00000213918,DNASE1-0.51471.0937e-073.5475e-09-0.4468imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2DNASE1T_cells_follicular_helperGSVA_HALLMARK_ADIPOGENESIS
chr15:34231060-34232550:-GBMEERENSG00000189339,SLC35E2B-0.49982.6643e-074.4264e-09-0.4444imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAT_cells_gamma_deltaGSVA_HALLMARK_ADIPOGENESIS
chr15:34231060-34232550:-GBMEERENSG00000113732,ATP6V0E10.50082.8263e-072.6782e-080.4234imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAMacrophages_M0GSVA_HALLMARK_MITOTIC_SPINDLE
chr15:34231060-34232550:-GBMEERENSG00000125447,GGA3-0.49633.8100e-071.3176e-09-0.4577imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAT_cells_gamma_deltaGSVA_HALLMARK_FATTY_ACID_METABOLISM
chr15:34231060-34232550:-GBMEERENSG00000234616,JRK-0.49623.8118e-075.0442e-08-0.4157imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAMonocytesGSVA_HALLMARK_XENOBIOTIC_METABOLISM
chr15:34231060-34232550:-GBMEERENSG00000185219,ZNF445-0.49005.6916e-071.3618e-09-0.4573imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr15:34231060-34232550:-GBMEERENSG00000178971,CTC1-0.48976.1360e-079.6154e-09-0.4355imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAT_cells_gamma_deltaGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr15:34231060-34232550:-GBMEERENSG00000215041,NEURL4-0.48936.1409e-076.5967e-08-0.4124imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY

More results



Top

4. Enriched editing regions and immune related splicing for SLC12A6


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000140199.10,SLC12A6
GBMEAGIRENSG00000175376.4chr1166000302:66000481:66001909:66002007-0.41327.8822e-051.0061e-07-0.4360imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;ELAVL3;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LARP4B;LARP7;LIN28;LIN28A;LIN28B;MBNL2;MOV10;MSI2;NONO;NOP56;NOP58;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM47;RBM5;RC3H1;RNF219;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;ZNF184NAMonocytesGSVA_HALLMARK_ADIPOGENESIS
ENSG00000140199.10,SLC12A6
GBMEAGIRENSG00000166707.6chrX104113194:104113573:104115251:104115842-0.33119.9565e-049.0246e-07-0.4411imageNCNBP;ELAVL1;FAM120A;FBL;FUS;HNRNPA2B1;HNRNPL;IGF2BP2;LIN28;MOV10;RANGAP1;RBFOX2;RBM5;TARDBPNAT_cells_CD4_memory_activatedGSVA_HALLMARK_MITOTIC_SPINDLE
ENSG00000140199.10,SLC12A6
GBMEAGIRENSG00000137880.4chr1540765619:40765921:40767225:40767543-0.39146.8809e-043.7153e-07-0.4034imageNBCCIP;BUD13;CNBP;CSTF2T;DDX3X;DGCR8;DKC1;EIF4A3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPC;HNRNPK;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;KHSRP;LIN28;LIN28B;MOV10;MSI2;NONO;NOP56;PCBP2;PRPF8;PTBP1;RBFOX2;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF10;SRSF3;SRSF9;TAF15;TIA1;TROVE2;U2AF1;U2AF2;UPF1NAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
ENSG00000140199.10,SLC12A6
GBMEAGIRENSG00000100413.12chr2241530686:41532157:41532603:41532745-0.36481.7350e-049.6906e-07-0.4297imageNADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LARP4B;LARP7;LIN28;LIN28A;LIN28B;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RNF219;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF10;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;ZNF184NAT_cells_gamma_deltaGSVA_HALLMARK_ADIPOGENESIS
chr15:34231060-34232550:-
GBMEERIRENSG00000148719.10chr1072332829:72334617:72335779:72335931-0.45634.5311e-055.8039e-08-0.4177imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2NAT_cells_gamma_deltaGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr15:34231060-34232550:-
GBMEERIRENSG00000099977.9chr2223973103:23973343:23973767:23973943-0.38943.9243e-048.3638e-08-0.4342imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;NOP58;PTBP1;U2AF2DDTMacrophages_M0GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
chr15:34231060-34232550:-
GBMEERIRENSG00000171962.13chr1718004362:18004494:18006182:18006253-0.39484.6957e-056.3041e-08-0.4678imageNEIF4A3;ELAVL1;IGF2BP2;NOP58;U2AF2NAMacrophages_M0GSVA_HALLMARK_BILE_ACID_METABOLISM
chr15:34231060-34232550:-
GBMEERIRENSG00000137880.4chr1540765619:40765921:40767225:40767543-0.39146.0617e-043.7153e-07-0.4034imageNCSTF2T;EIF4A3;IGF2BP2;PTBP1;U2AF2NAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr15:34231060-34232550:-
GBMEERA3ENSG00000115355.11chr255291675:55291775:55288177:55288355:55288177:552911640.39689.5000e-044.7178e-080.4166imageNCSTF2T;EIF4A3;ELAVL1;IGF2BP2;MSI1;NOP58;PTBP1;U2AF2CCDC88AMonocytesGSVA_HALLMARK_MITOTIC_SPINDLE
ENSG00000140199.10,SLC12A6
GBMEAGIRENSG00000114021.7chr3100345584:100345730:100346180:100346255-0.21273.6393e-022.6254e-06-0.4221imageNACIN1;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LARP4B;LIN28;LIN28B;MOV10;MSI1;NOP56;NOP58;PRPF8;PTBP1;RBFOX2;RBM10;RBM47;RNF219;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZNF184NADendritic_cells_restingGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION

More results



Top

5. Enriched editing regions and immune infiltration for SLC12A6


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr15:34231060-34232550:-ACCEERB_cells_naive3.3550e-02-0.3287image
ENSG00000140199.10,SLC12A6ACCEAGB_cells_naive2.8409e-02-0.3383image
chr15:34231060-34232550:-BLCAEERT_cells_CD4_memory_activated6.2380e-040.1897image
ENSG00000140199.10,SLC12A6BLCAEAGT_cells_CD4_memory_activated7.2751e-040.1871image
chr15:34231060-34232550:-BRCAEERB_cells_naive2.9196e-03-0.1015image
ENSG00000140199.10,SLC12A6BRCAEAGB_cells_naive2.9578e-03-0.1013image
chr15:34231060-34232550:-CESCEERT_cells_CD81.4473e-020.1473image
ENSG00000140199.10,SLC12A6CESCEAGT_cells_CD81.4610e-020.1471image
chr15:34231060-34232550:-COADEERB_cells_memory2.1658e-020.1683image
ENSG00000140199.10,SLC12A6COADEAGEosinophils3.3349e-040.2596image
chr15:34231060-34232550:-DLBCEERNK_cells_activated4.6367e-020.4502image
ENSG00000140199.10,SLC12A6DLBCEAGNK_cells_activated2.9279e-020.4874image
chr15:34231060-34232550:-ESCAEERDendritic_cells_resting1.2106e-03-0.2529image
ENSG00000140199.10,SLC12A6ESCAEAGT_cells_CD81.2380e-030.2524image
chr15:34231060-34232550:-GBMEERT_cells_gamma_delta1.8384e-050.3326image
ENSG00000140199.10,SLC12A6GBMEAGT_cells_gamma_delta1.8384e-050.3326image
chr15:34231060-34232550:-HNSCEERMacrophages_M16.0045e-090.2678image
ENSG00000140199.10,SLC12A6HNSCEAGMacrophages_M16.0045e-090.2678image
chr15:34231060-34232550:-KICHEERMonocytes8.5160e-030.3395image
ENSG00000140199.10,SLC12A6KICHEAGMonocytes8.5160e-030.3395image
chr15:34231060-34232550:-KIRCEERT_cells_regulatory_(Tregs)1.6433e-050.2256image
ENSG00000140199.10,SLC12A6KIRCEAGT_cells_regulatory_(Tregs)1.3551e-040.2004image
chr15:34231060-34232550:-KIRPEERT_cells_CD82.9659e-020.1376image
ENSG00000140199.10,SLC12A6KIRPEAGT_cells_CD83.4932e-020.1329image
chr15:34231060-34232550:-LAMLEERT_cells_follicular_helper1.8560e-020.1981image
chr15:34249281-34250056:-LAMLEERT_cells_regulatory_(Tregs)1.0235e-020.2679image
chr15:34231060-34232550:-LGGEERMacrophages_M15.5890e-060.1978image
ENSG00000140199.10,SLC12A6LGGEAGMacrophages_M15.5890e-060.1978image
chr15:34231060-34232550:-LUADEERMast_cells_resting8.9573e-03-0.1239image
ENSG00000140199.10,SLC12A6LUADEAGMast_cells_resting7.4425e-03-0.1269image
chr15:34231060-34232550:-LUSCEERT_cells_CD89.0815e-040.1522image
ENSG00000140199.10,SLC12A6LUSCEAGT_cells_CD89.1690e-040.1521image
chr15:34231060-34232550:-MESOEERMacrophages_M07.3795e-030.3345image
ENSG00000140199.10,SLC12A6MESOEAGMacrophages_M07.3795e-030.3345image
chr15:34231060-34232550:-OVEERT_cells_gamma_delta1.3512e-040.2350image
ENSG00000140199.10,SLC12A6OVEAGT_cells_gamma_delta1.3815e-040.2346image
chr15:34231060-34232550:-PAADEERT_cells_follicular_helper2.1675e-020.1803image
ENSG00000140199.10,SLC12A6PAADEAGT_cells_follicular_helper2.1675e-020.1803image
chr15:34231060-34232550:-PCPGEERNK_cells_resting1.3883e-030.2745image
ENSG00000140199.10,SLC12A6PCPGEAGNK_cells_resting1.3883e-030.2745image
chr15:34231060-34232550:-PRADEERNK_cells_resting6.8660e-040.1909image
ENSG00000140199.10,SLC12A6PRADEAGNK_cells_resting8.1525e-040.1880image
chr15:34231060-34232550:-SARCEEREosinophils1.6546e-030.2280image
ENSG00000140199.10,SLC12A6SARCEAGEosinophils1.6546e-030.2280image
chr15:34231060-34232550:-SKCMEERT_cells_CD83.6426e-030.1599image
ENSG00000140199.10,SLC12A6SKCMEAGT_cells_CD83.7314e-030.1595image
chr15:34231060-34232550:-STADEERT_cells_CD81.6495e-050.2296image
ENSG00000140199.10,SLC12A6STADEAGT_cells_CD81.1715e-050.2335image
chr15:34231060-34232550:-TGCTEERMonocytes3.9384e-020.1845image
ENSG00000140199.10,SLC12A6TGCTEAGMonocytes3.9384e-020.1845image
chr15:34231060-34232550:-THCAEERT_cells_CD4_memory_resting1.3355e-02-0.1131image
ENSG00000140199.10,SLC12A6THCAEAGT_cells_CD4_memory_resting1.3355e-02-0.1131image
chr15:34231060-34232550:-THYMEERB_cells_memory1.2742e-030.3344image
ENSG00000140199.10,SLC12A6THYMEAGB_cells_memory2.9848e-030.3079image


Top

6. Enriched editing regions and immune gene sets for SLC12A6


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot
chr15:34231060-34232550:-LUSCEER2.6261e-02image3.1817e-020.0988image
ENSG00000140199.10,SLC12A6LUSCEAG2.6371e-02image3.2088e-020.0987image


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
ENSG00000140199.10,SLC12A6HNSCEAG6.5016e-050.18571.3317e-02-0.11576.6654e-040.15865.4143e-040.1612image
chr15:34231060-34232550:-HNSCEER6.5016e-050.18571.3317e-02-0.11576.6654e-040.15865.4143e-040.1612image
ENSG00000140199.10,SLC12A6LUADEAG1.6953e-030.14861.4550e-020.11594.6723e-020.09443.8444e-020.0983image
chr15:34231060-34232550:-LUADEER1.5788e-030.14951.5270e-020.11514.4919e-020.09523.1692e-020.1020image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr15:34231060-34232550:-ACCGSVA_HALLMARK_KRAS_SIGNALING_UPEER1.7127e-02-0.3660image
ENSG00000140199.10,SLC12A6ACCGSVA_HALLMARK_KRAS_SIGNALING_UPEAG1.9508e-02-0.3591image
ENSG00000140199.10,SLC12A6BLCAGSVA_HALLMARK_PROTEIN_SECRETIONEAG4.1889e-05-0.2259image
chr15:34231060-34232550:-BLCAGSVA_HALLMARK_PROTEIN_SECRETIONEER7.5824e-05-0.2187image
ENSG00000140199.10,SLC12A6BRCAGSVA_HALLMARK_GLYCOLYSISEAG1.2349e-070.1792image
chr15:34231060-34232550:-BRCAGSVA_HALLMARK_GLYCOLYSISEER1.6501e-070.1776image
chr15:34231060-34232550:-CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.0945e-050.2447image
ENSG00000140199.10,SLC12A6CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.1032e-050.2447image
ENSG00000140199.10,SLC12A6COADGSVA_HALLMARK_HEME_METABOLISMEAG2.4204e-03-0.2206image
chr15:34231060-34232550:-DLBCGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER8.0011e-030.5750image
ENSG00000140199.10,SLC12A6DLBCGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG7.2827e-030.5805image
ENSG00000140199.10,SLC12A6ESCAGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEAG5.2495e-06-0.3502image
chr15:34231060-34232550:-ESCAGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEER9.1806e-06-0.3417image
ENSG00000140199.10,SLC12A6GBMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.4236e-060.3638image
chr15:34231060-34232550:-GBMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.4236e-060.3638image
ENSG00000140199.10,SLC12A6HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG8.6822e-200.4083image
chr15:34231060-34232550:-HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER8.6822e-200.4083image
chr15:34231060-34232550:-KICHGSVA_HALLMARK_XENOBIOTIC_METABOLISMEER3.1874e-030.3777image
ENSG00000140199.10,SLC12A6KICHGSVA_HALLMARK_XENOBIOTIC_METABOLISMEAG3.1874e-030.3777image
ENSG00000140199.10,SLC12A6KIRCGSVA_HALLMARK_MITOTIC_SPINDLEEAG4.9511e-06-0.2387image
chr15:34231060-34232550:-KIRCGSVA_HALLMARK_MITOTIC_SPINDLEEER2.9876e-06-0.2440image
ENSG00000140199.10,SLC12A6KIRPGSVA_HALLMARK_MITOTIC_SPINDLEEAG3.3330e-10-0.3825image
chr15:34231060-34232550:-KIRPGSVA_HALLMARK_MITOTIC_SPINDLEEER2.3966e-10-0.3868image
chr15:34270150-34270647:-LAMLGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER2.7012e-020.2399image
chr15:34231060-34232550:-LAMLGSVA_HALLMARK_HEME_METABOLISMEER7.7807e-03-0.2233image
ENSG00000140199.10,SLC12A6LAMLGSVA_HALLMARK_PEROXISOMEEAG2.3358e-02-0.1876image
ENSG00000140199.10,SLC12A6LGGGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.5013e-120.3010image
chr15:34231060-34232550:-LGGGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER2.5013e-120.3010image
ENSG00000140199.10,SLC12A6LIHCGSVA_HALLMARK_MITOTIC_SPINDLEEAG6.0777e-03-0.3100image
ENSG00000140199.10,SLC12A6LUADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG3.2231e-080.2586image
chr15:34231060-34232550:-LUADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER1.8345e-080.2631image
chr15:34231060-34232550:-LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER8.2587e-110.2932image
ENSG00000140199.10,SLC12A6LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG8.3130e-110.2931image
ENSG00000140199.10,SLC12A6MESOGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG3.5302e-020.2657image
chr15:34231060-34232550:-MESOGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER3.5302e-020.2657image
chr15:34231060-34232550:-OVGSVA_HALLMARK_MITOTIC_SPINDLEEER3.6256e-04-0.2199image
ENSG00000140199.10,SLC12A6OVGSVA_HALLMARK_MITOTIC_SPINDLEEAG4.0103e-04-0.2183image
ENSG00000140199.10,SLC12A6PAADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG9.4991e-030.2032image
chr15:34231060-34232550:-PAADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER9.4991e-030.2032image
chr15:34231060-34232550:-PRADGSVA_HALLMARK_UV_RESPONSE_DNEER3.6046e-04-0.2004image
ENSG00000140199.10,SLC12A6PRADGSVA_HALLMARK_UV_RESPONSE_DNEAG3.3711e-04-0.2010image
ENSG00000140199.10,SLC12A6READGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG1.4699e-020.2926image
chr15:34231060-34232550:-READGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER1.4699e-020.2926image
chr15:34231060-34232550:-SARCGSVA_HALLMARK_XENOBIOTIC_METABOLISMEER3.2618e-030.2135image
ENSG00000140199.10,SLC12A6SARCGSVA_HALLMARK_XENOBIOTIC_METABOLISMEAG3.2618e-030.2135image
ENSG00000140199.10,SLC12A6SKCMGSVA_HALLMARK_UV_RESPONSE_UPEAG4.4028e-090.3164image
chr15:34231060-34232550:-SKCMGSVA_HALLMARK_UV_RESPONSE_UPEER5.6009e-090.3143image
ENSG00000140199.10,SLC12A6STADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.5793e-070.2731image
chr15:34231060-34232550:-STADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER1.0528e-070.2815image
ENSG00000140199.10,SLC12A6TGCTGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG5.7438e-040.3037image
chr15:34231060-34232550:-TGCTGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER5.7438e-040.3037image
chr15:34231060-34232550:-THCAGSVA_HALLMARK_UV_RESPONSE_DNEER3.6545e-08-0.2486image
ENSG00000140199.10,SLC12A6THCAGSVA_HALLMARK_UV_RESPONSE_DNEAG3.6545e-08-0.2486image
ENSG00000140199.10,SLC12A6THYMGSVA_HALLMARK_MITOTIC_SPINDLEEAG7.4370e-06-0.4505image
chr15:34231060-34232550:-THYMGSVA_HALLMARK_MITOTIC_SPINDLEEER5.9509e-06-0.4570image
chr15:34231060-34232550:-UCECGSVA_HALLMARK_UV_RESPONSE_UPEER2.7265e-020.2341image


Top

7. Enriched editing regions and drugs for SLC12A6


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000140199.10,SLC12A6BLCAGDC.0449EAG3.3019e-05-0.2288image
chr15:34231060-34232550:-BLCAGDC.0449EER3.3690e-05-0.2289image
chr15:34231060-34232550:-BRCAGNF.2EER1.2617e-04-0.1305image
ENSG00000140199.10,SLC12A6BRCAGNF.2EAG2.0343e-04-0.1264image
ENSG00000140199.10,SLC12A6CESCAZD.2281EAG2.2795e-05-0.2524image
chr15:34231060-34232550:-CESCAZD.2281EER2.2975e-05-0.2523image
chr15:34231060-34232550:-CHOLAMG.706EER1.9246e-030.5794image
ENSG00000140199.10,SLC12A6CHOLAMG.706EAG1.8539e-030.5810image
ENSG00000140199.10,SLC12A6COADBMS.509744EAG2.7265e-030.2180image
ENSG00000140199.10,SLC12A6DLBCAS601245EAG4.9843e-030.6019image
chr15:34231060-34232550:-DLBCCCT007093EER5.8938e-030.5926image
chr15:34231060-34232550:-ESCAGDC.0449EER7.3559e-09-0.4374image
ENSG00000140199.10,SLC12A6ESCAGDC.0449EAG1.1266e-08-0.4324image
ENSG00000140199.10,SLC12A6GBMErlotinibEAG3.2404e-09-0.4478image
chr15:34231060-34232550:-GBMErlotinibEER3.2404e-09-0.4478image
chr15:34231060-34232550:-HNSCCGP.60474EER1.4174e-14-0.3495image
ENSG00000140199.10,SLC12A6HNSCCGP.60474EAG1.4174e-14-0.3495image
chr15:34231060-34232550:-KICHJNJ.26854165EER1.1297e-02-0.3277image
ENSG00000140199.10,SLC12A6KICHJNJ.26854165EAG1.1297e-02-0.3277image
ENSG00000140199.10,SLC12A6KIRCAZD6244EAG1.5924e-06-0.2505image
chr15:34231060-34232550:-KIRCCEP.701EER5.9612e-09-0.3018image
chr15:34231060-34232550:-KIRPAZD6482EER1.9800e-090.3679image
ENSG00000140199.10,SLC12A6KIRPAZD6482EAG2.8444e-080.3408image
chr15:34231060-34232550:-LAMLATRAEER2.2685e-030.2551image
chr15:34249281-34250056:-LAMLDocetaxelEER1.5888e-02-0.2522image
ENSG00000140199.10,SLC12A6LGGJW.7.52.1EAG1.7665e-18-0.3720image
chr15:34231060-34232550:-LGGJW.7.52.1EER1.7665e-18-0.3720image
ENSG00000140199.10,SLC12A6LIHCBAY.61.3606EAG1.0273e-030.3670image
ENSG00000140199.10,SLC12A6LUADCHIR.99021EAG9.9557e-040.1561image
chr15:34231060-34232550:-LUADCHIR.99021EER1.0831e-030.1549image
ENSG00000140199.10,SLC12A6LUSCGDC.0449EAG8.7320e-07-0.2241image
chr15:34231060-34232550:-LUSCGDC.0449EER8.6598e-07-0.2242image
ENSG00000140199.10,SLC12A6MESOBMS.536924EAG4.4798e-03-0.3535image
chr15:34231060-34232550:-MESOBMS.536924EER4.4798e-03-0.3535image
ENSG00000140199.10,SLC12A6OVImatinibEAG5.5472e-080.3297image
chr15:34231060-34232550:-OVImatinibEER4.5237e-080.3318image
chr15:34231060-34232550:-PAADAxitinibEER3.9473e-030.2274image
ENSG00000140199.10,SLC12A6PAADAxitinibEAG3.9473e-030.2274image
ENSG00000140199.10,SLC12A6PCPGABT.263EAG1.9351e-020.2026image
chr15:34231060-34232550:-PCPGABT.263EER1.9351e-020.2026image
ENSG00000140199.10,SLC12A6PRADBX.795EAG5.4499e-030.1565image
chr15:34231060-34232550:-PRADBX.795EER2.1985e-030.1725image
chr15:34231060-34232550:-READImatinibEER1.7879e-040.4363image
ENSG00000140199.10,SLC12A6READImatinibEAG1.7879e-040.4363image
chr15:34231060-34232550:-SARCFH535EER1.1892e-030.2347image
ENSG00000140199.10,SLC12A6SARCFH535EAG1.1892e-030.2347image
chr15:34231060-34232550:-SKCMAG.014699EER5.7835e-080.2936image
ENSG00000140199.10,SLC12A6SKCMAG.014699EAG5.2013e-080.2946image
ENSG00000140199.10,SLC12A6STADBMS.509744EAG1.2312e-07-0.2800image
chr15:34231060-34232550:-STADBMS.509744EER4.8669e-07-0.2669image
ENSG00000140199.10,SLC12A6TGCTAZ628EAG9.5296e-06-0.3845image
chr15:34231060-34232550:-TGCTAZ628EER9.5296e-06-0.3845image
ENSG00000140199.10,SLC12A6THCAEmbelinEAG1.1769e-150.3552image
chr15:34231060-34232550:-THCAEmbelinEER1.1769e-150.3552image
ENSG00000140199.10,SLC12A6THYMCI.1040EAG3.1541e-07-0.5058image
chr15:34231060-34232550:-THYMCI.1040EER6.8843e-07-0.4954image
ENSG00000140199.10,SLC12A6UCECDMOGEAG1.0438e-030.3382image
chr15:34231060-34232550:-UCECDMOGEER8.8962e-040.3462image
ENSG00000140199.10,SLC12A6UCSMidostaurinEAG3.2674e-03-0.5040image
chr15:34231060-34232550:-UCSMidostaurinEER3.2674e-03-0.5040image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType
chr15:34231060-34232550:-ENST00000290209.8Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000290209.8Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000354181.6Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000397702.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000397707.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000458406.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000558589.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000558667.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34249281-34250056:-ENST00000560611.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000290209.8Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000354181.6Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000397702.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000397707.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000458406.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000558589.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000558667.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34270150-34270647:-ENST00000560611.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000290209.8Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000354181.6Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000397702.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000397707.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000458406.5Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000558589.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000558667.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug
chr15:34286153-34286723:-ENST00000560611.4Q9UHW9DB00761Potassium chlorideSmallMoleculeDrug